Fundz

Volitionrx Secures Approximately $5.5 Million In Belgium Regional Government Financing From Wallonie Entreprendre

PUBLIC · VNRXDec 05, 2023

Amount Raised

$5.5 Million

Round Type

Funding Round

HendersonBiotechnologyHealth CareGeneticsTherapeuticsHealth Diagnostics

Investors

WeWallonie Entreprendre S.A.

Description

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has closed on an aggregate of Euro 5.0 million (approximately $5.5 million) in financing from Wallonie Entreprendre S.A. ("WE") in Belgium.

Quick answer

VolitionRx raised $5.5 Million in a Funding Round round, dated December 5, 2023. Investors: We and Wallonie Entreprendre S.A. VolitionRx is based in Henderson, Nevada, United States.

How much did VolitionRx raise?
VolitionRx raised $5.5 Million in a Funding Round round on December 5, 2023.
Who invested in VolitionRx?
We and Wallonie Entreprendre S.A. are named as investors in this round.
What does VolitionRx do?
VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment..
Where is VolitionRx based and how big is it?
VolitionRx is based in Henderson, Nevada, United States. Fundz records about 86 employees.
Who are the decision-makers at VolitionRx?
Fundz holds 5 contacts at VolitionRx, including the Group Chief Marketing & Communications Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as VolitionRx that raised within 45 days of this round, from Fundz verified event records.

  • Calidi Biotherapeutics raised $10K on January 19, 2024.
  • Cleveland Diagnostics raised $75M (Funding Round) on January 17, 2024.
  • Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
  • Cleveland Diagnostics raised $56M on January 16, 2024.
  • Gallant raised $15M (Series A) on January 8, 2024.
  • Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.

Who to call at VolitionRx, and when

A new round usually means VolitionRx is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VolitionRx raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VolitionRx, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VolitionRx. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VolitionRx

Location

1489 West Warm Springs Road

Henderson, Nevada, United States

About

VolitionRx Limited is a multi-national epigenetics company dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. The company is focused on advancing the science of epigenetics and developing simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VolitionRx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Verified contactsLouise B., Group Chief Marketing & Communications… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VolitionRx's next move

See what Strategic adds

VolitionRx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.